About PEPperPRINT
PEPperPRINT is a company based in Heidelberg (Germany) founded in 2010. PEPperPRINT has raised $676 thousand across 3 funding rounds from investors including European Union and High-Tech Gründerfonds. PEPperPRINT offers products and services including PEPperCHIP Peptide Microarrays and PEPperMAP Services. PEPperPRINT operates in a competitive market with competitors including Inflammatix, Agendia, GenomeDx Biosciences, Affymetrix and Akonni, among others.
- Headquarter Heidelberg, Germany
- SectorsHealthcare
- Website pepperprint.com
- Social LinkedIn X Facebook YouTube
- Legal Name Pepperprint Gmbh
- Total Equity Funding$676K (USD)
in 3 rounds
- Latest Funding Round$448.73K (USD), Grant
Aug 2020
- InvestorsEuropean Union
& 1 more
Products & Services of PEPperPRINT
PEPperPRINT offers a comprehensive portfolio of products and services, including PEPperCHIP Peptide Microarrays and PEPperMAP Services.
Tools for high-throughput peptide screening in scientific studies.
Services for identifying antibody binding sequences accurately.
Apps and channels of PEPperPRINT
its YouTube channel PEPperPRINT has 99 subscribers and 29 videos.
Videos from PEPperPRINT
The most watched videos on PEPperPRINT's YouTube channel, PEPperPRINT (99 subscribers). Click a video to play it here.
More on PEPperPRINT.
Funding Insights of PEPperPRINT
PEPperPRINT has successfully raised a total of $676K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $448.73 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $676,000
- Total Rounds 3
- Last Round Grant — $448,727
- First Round $676,000
(Mar 2010)
- Investors Count 2
All 3 funding rounds of PEPperPRINT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $448,727 | Grant | – | – | |
| Jan 2020 | $423,396 | Grant | – | – | |
| Mar 2010 | $676,000 | Seed | – | HTGF | – |
2 investors in total: 2 institutional.
Investors in PEPperPRINT
PEPperPRINT has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in high-tech startups by HTGF. | – | htgf.de | Bonn, Germany | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for PEPperPRINT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PEPperPRINT
3 dated milestones of PEPperPRINT across 10 years, from founding to its latest funding, stage changes and deals.
- Founded PEPperPRINT is founded.
- Funding First funding round of $676K.
- Funding Latest funding round, Grant, of $449K.
Competitors of PEPperPRINT
PEPperPRINT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Agendia, GenomeDx Biosciences, Affymetrix and Akonni, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| agendia.com | 2003 | Irvine, United States | $123M | 203 | Genomic diagnostic products for cancer treatment are provided. | |
| genomedx.com | 2008 | San Diego, United States | $69.75M | 159 | Genomic tests for urologic cancers are developed and commercialized. | |
| affymetrix.com | 1991 | Santa Clara, United States | – | 721 | Provider of technologies for multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level | |
| akonni.com | 2003 | Frederick, United States | $39.75M | 12 | Molecular diagnostics for complex infections are developed by Akonni. | |
| kromatid.com | 2007 | Fort Collins, United States | $14.54M | – | Molecular and genetic tests for detecting disease-causing mutations are provided. | |
| indevr.com | 2003 | Boulder, United States | $16M | – | Biotherapeutics, vaccines, and diagnostic products are manufactured and developed. | |
| pamgene.com | 1999 | Virginia, United States | $17.89M | – | PamGene is focused on kinome-based biomarkers for drug development and therapy. | |
| synplogen.com | 2017 | Tsuruoka, Japan | – | – | DNA synthesis technology is developed using microbial methods. | |
| exiqon.com | 1995 | Vedbaek, Denmark | $22.9M | 65 | LNA-based tools are developed for diagnostics and research applications. |
Detailed competitors of PEPperPRINT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PEPperPRINT
The website of PEPperPRINT (pepperprint.com) receives about 8.7K visits a month.
- Monthly visits8.7K
▲ 323.7% vs previous month
Websites whose visitors overlap most with PEPperPRINT. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| metabion.com | 100% | – | #3,974,909 | View details | |
| bio-m.org | 87% | 13.9K | #1,671,971 | View details | |
| promocell.com | 74% | – | #944,821 | View details | |
| biocat.com | 74% | 37.9K | #866,969 | View details | |
| sabiosciences.com | 60% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 18 similar websites and full traffic analytics for PEPperPRINT
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 18 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Pepperprint
Complete news archive for PEPperPRINT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to PEPperPRINT
10 companies that operate in the same segment as PEPperPRINT (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PEPperPRINT
PEPperPRINT was founded in 2010.
PEPperPRINT is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
PEPperPRINT is a funded company, having raised a total of $676K across 3 funding rounds to date. The company's 1st funding round was a Seed of $676K, raised on Mar 2010.
PEPperPRINT was founded in 2010 in Heidelberg, Germany, and operates within the biotechnology sector. A platform for high-density peptide microarrays is offered, enabling custom designs based on specific peptide or protein sequences. These microarrays are utilized for applications such as epitope mapping, antigen discovery, serum antibody profiling, and vaccine development. Services include biomarker identification, humoral immune response analysis, and protein target optimization, supporting research in immunology and drug development.
PEPperPRINT's top competitors include Inflammatix, Agendia and KromaTiD.
PEPperPRINT offers PEPperCHIP Peptide Microarrays and PEPperMAP Services.
PEPperPRINT has 2 investors. Key investors include European Union, and High-Tech Gründerfonds.
PEPperPRINT operates through Pepperprint Gmbh.